论文部分内容阅读
鼻咽癌患者存在抗EB病毒抗体,曾由我国台湾、香港、非洲、日本及美国等地观察者采用间接免疫荧光抗体技术所证实。而且从鼻咽癌活检组所培养出的细胞,亦含有疱疹型病毒,这些结果提示EB病毒或可致发鼻咽癌,如同可引起传染性单核细胞增多症及Burkitt氏淋巴瘤一样。本文系根据台北台湾大学院耳鼻喉科对鼻咽癌病案的追溯观察结果,将报告:(1)鼻咽癌临床分期及随访时的抗EB病毒抗体滴度,以及正常成人、头颈部炎性疾病及鼻咽癌以外的新生物上述滴度;(2)放疗后的抗EB病毒滴度;(3)局部病变复发及有远处转移的滴度。
The presence of anti-EB virus antibodies in patients with nasopharyngeal carcinoma has been confirmed by observers in Taiwan, Hong Kong, Africa, Japan and the United States using indirect immunofluorescence antibody technology. Furthermore, the cells cultured from the nasopharyngeal cancer biopsy group also contained the herpes-type virus. These results suggest that the EB virus may cause nasopharyngeal carcinoma, as can cause infectious mononucleosis and Burkitt’s lymphoma. Based on the retrospective results of the ENT department of Otolaryngology in Taipei, Taiwan University, we will report: (1) anti-EB virus antibody titers at clinical stage and follow-up of nasopharyngeal carcinoma, and normal adults, head and neck inflammation Diseases and titers of new organisms other than nasopharyngeal carcinoma; (2) Anti-EB virus titers after radiotherapy; (3) Recurrence of local lesions and titers with distant metastases.